Cargando…

Prediction of Residual Risk by Ceramide‐Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy

BACKGROUND: Identification of patients with stable coronary heart disease who are at significant residual risk could be helpful for targeted prevention. Our aim was to determine the prognostic value of the recently introduced ceramide‐ and phospholipid‐based risk score, the Cardiovascular Event Risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hilvo, Mika, Wallentin, Lars, Ghukasyan Lakic, Tatevik, Held, Claes, Kauhanen, Dimple, Jylhä, Antti, Lindbäck, Johan, Siegbahn, Agneta, Granger, Christopher B., Koenig, Wolfgang, Stewart, Ralph A. H., White, Harvey, Laaksonen, Reijo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660846/ https://www.ncbi.nlm.nih.gov/pubmed/32375553 http://dx.doi.org/10.1161/JAHA.119.015258

Ejemplares similares

Absolute and relative risk prediction in cardiovascular primary prevention with a modified SCORE chart incorporating ceramide-phospholipid risk score and diabetes mellitus
por: Hilvo, Mika, et al.
Publicado: (2021)

Ceramides and phospholipids in plasma extracellular vesicles are associated with high risk of major cardiovascular events after carotid endarterectomy
por: Timmerman, Nathalie, et al.
Publicado: (2022)

Ceramides and Ceramide Scores: Clinical Applications for Cardiometabolic Risk Stratification
por: Hilvo, Mika, et al.
Publicado: (2020)

A Randomized Controlled Dietary Intervention Improved the Serum Lipid Signature towards a Less Atherogenic Profile in Patients with Rheumatoid Arthritis
por: Lindqvist, Helen M., et al.
Publicado: (2021)

Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries: Results From the PLATO Trial
por: Hjort, Marcus, et al.
Publicado: (2022)

Assessment of plasma ceramides as predictor for subclinical atherosclerosis
por: Mishra, Pashupati P., et al.
Publicado: (2021)

Serum ceramides in early pregnancy as predictors of gestational diabetes
por: Mustaniemi, Sanna, et al.
Publicado: (2023)

Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
por: Laaksonen, Reijo, et al.
Publicado: (2016)

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation
por: Hijazi, Ziad, et al.
Publicado: (2016)

Plasma ceramides independently predict all-cause mortality in men aged 85(+)
por: Strandberg, Timo E, et al.
Publicado: (2022)

A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score
por: Hijazi, Ziad, et al.
Publicado: (2018)

Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
por: Held, Claes, et al.
Publicado: (2017)

Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial
por: Ueland, Thor, et al.
Publicado: (2018)

Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials
por: Hijazi, Ziad, et al.
Publicado: (2020)

Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)
por: Siegbahn, Agneta, et al.
Publicado: (2023)

Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study
por: Wallentin, Lars, et al.
Publicado: (2021)

Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial Fibrillation
por: Hijazi, Ziad, et al.
Publicado: (2020)

Mixing brain cerebrosides with brain ceramides, cholesterol and phospholipids
por: González-Ramírez, Emilio J., et al.
Publicado: (2019)

Oxidized Phospholipids Induce Ceramide Accumulation in RAW 264.7 Macrophages: Role of Ceramide Synthases
por: Halasiddappa, Lingaraju M., et al.
Publicado: (2013)

Legumain in Acute Coronary Syndromes: A Substudy of the PLATO (Platelet Inhibition and Patient Outcomes) Trial
por: Gregersen, Ida, et al.
Publicado: (2020)

Interleukin‐18 in patients with acute coronary syndromes
por: Åkerblom, Axel, et al.
Publicado: (2019)

Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation
por: Hijazi, Ziad, et al.
Publicado: (2020)

Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation
por: Pol, Tymon, et al.
Publicado: (2021)

Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation
por: Hijazi, Ziad, et al.
Publicado: (2022)

Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation
por: Benz, Alexander P, et al.
Publicado: (2023)

Genome-Wide Association Study Identifies That the ABO Blood Group System Influences Interleukin-10 Levels and the Risk of Clinical Events in Patients with Acute Coronary Syndrome
por: Johansson, Åsa, et al.
Publicado: (2015)

Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time
por: Hijazi, Ziad, et al.
Publicado: (2017)

Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas
por: Pol, Tymon, et al.
Publicado: (2021)

Physical activity in patients with stable coronary heart disease: an international perspective
por: Stewart, Ralph, et al.
Publicado: (2013)

Molecular Lipids Identify Cardiovascular Risk and Are Efficiently Lowered by Simvastatin and PCSK9 Deficiency
por: Tarasov, Kirill, et al.
Publicado: (2014)

Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y(12) Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial
por: Franchi, Francesco, et al.
Publicado: (2019)

Long chain ceramides raise the main phase transition of monounsaturated phospholipids to physiological temperature
por: Takahashi, Hiroshi, et al.
Publicado: (2022)

Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events
por: Attelind, Sofia, et al.
Publicado: (2022)

Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study
por: Storey, Robert F., et al.
Publicado: (2014)

Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial
por: Zobel, Emilie H, et al.
Publicado: (2021)

Liver-specific deletion of the Plpp3 gene alters plasma lipid composition and worsens atherosclerosis in apoE(−/−) mice
por: Busnelli, Marco, et al.
Publicado: (2017)

Fish oil and krill oil differentially modify the liver and brain lipidome when fed to mice
por: Skorve, Jon, et al.
Publicado: (2015)

Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease – A STABILITY Substudy
por: Held, Claes, et al.
Publicado: (2022)

Changes in Phospholipid/Ceramide Profiles and Eicosanoid Levels in the Plasma of Rats Irradiated with UV Rays and Treated Topically with Cannabidiol
por: Łuczaj, Wojciech, et al.
Publicado: (2021)

Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
por: Sandhu, Roopinder K, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5qgaqghlvuk70e2kr7adet023l